PF-00217830
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-00217830, covering 2012-04-18 to 2012-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia [Phase 2]